Journal of Targeted Oncology Research

Frequency : Bi-Annual (Two issues per year)
Editorial & Review Timeline
3 - 6 Days Initial Quality Review
30 Days Peer Evaluation Summary
45 - 60 Days Complete Editorial Processing Time

Targeted Therapies

Targeted therapies are designed to specifically identify and treat cancer cells while minimizing damage to healthy tissues. Research in this area focuses on molecular targets, receptor-based treatments, signal pathway inhibitors, and personalized therapeutic approaches. These strategies aim to improve treatment precision, reduce adverse effects, and enhance patient outcomes in oncology care.